John H. Stewart named center director of LSU Health New Orleans/LCMC Health Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

John H. Stewart was named center director of the LSU Health New Orleans/LCMC Health Cancer Center. 

He will also join the LSU Health New Orleans School of Medicine faculty as a professor of surgery.

Stewart will set the overall mission, vision and direction for multidisciplinary cancer care and cancer clinical research programs for LSU Health New Orleans and LCMC Health in his new leadership role. 

He and his team will develop a robust cancer clinical trials program, leverage resources to build an innovative targeted cancer research enterprise and create a comprehensive community outreach and engagement program to reduce cancer risk behaviors and cancer incidence. 

Initiatives will integrate disease-specific research and care delivery into a comprehensive patient-oriented approach to benefit patients of Louisiana and surrounding regions, including those currently underserved in accessing leading-edge cancer care.

Stewart, originally from Shreveport, was recruited from the University of Illinois College of Medicine in Chicago. There, he was a University of Illinois Presidential Scholar, professor of surgery in the College of Medicine, deputy director of the University of Illinois Cancer Center, and physician executive for oncology sciences at the University of Illinois Health.

Stewart’s role will be effective July 1.

Table of Contents

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login